NeuBase Therapeutics Stock Forecast - Price Action Indicator
| NBSEDelisted Stock | USD 1.62 0.17 9.50% |
NeuBase Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast NeuBase Therapeutics stock prices and determine the direction of NeuBase Therapeutics's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of NeuBase Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns.
NeuBase |
| Previous Price Action Indicator | Price Action Indicator | Trend |
| (0.03) | (0.01) |
| Check NeuBase Therapeutics Volatility | Backtest NeuBase Therapeutics | Trend Details |
NeuBase Therapeutics Trading Date Momentum
| On July 24 2023 NeuBase Therapeutics was traded for 1.62 at the closing time. The top price for the day was 1.83 and the lowest listed price was 1.60 . The trading volume for the day was 82.9 K. The trading history from July 24, 2023 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 7.43% . The trading delta at closing time against the current closing price is 2.29% . |
Price Action Indicator (or PAIN) was developed by Michael B. Geraty and published in 'Futures' magazine in August 1997.
Compare NeuBase Therapeutics to competition
View NeuBase Therapeutics Related Equities
| Risk & Return | Correlation |
NeuBase Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how NeuBase Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading NeuBase Therapeutics shares will generate the highest return on investment. By undertsting and applying NeuBase Therapeutics stock market strength indicators, traders can identify NeuBase Therapeutics entry and exit signals to maximize returns.
NeuBase Therapeutics Risk Indicators
The analysis of NeuBase Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in NeuBase Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting neubase stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 4.27 | |||
| Standard Deviation | 6.12 | |||
| Variance | 37.5 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Consideration for investing in NeuBase Stock
If you are still planning to invest in NeuBase Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the NeuBase Therapeutics' history and understand the potential risks before investing.
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |